HULTA PHARMA Fact Sheet, HULTA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HULTA PHARMA Fact Sheet    (HTPH)


REVEALED: Brijesh Bhatia's Private Telegram Channel (JOIN NOW)


Here is the latest financial fact sheet of HULTA PHARMA. For more details, see the HULTA PHARMA quarterly results and HULTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

HULTA PHARMA Price History

Price Rs 4.6
Mkt Cap Rs m 34
Vol '000 0.5
P/E X -16.9
P/CF X -33.0
EPS (TTM) Rs -0.3
% ch % 0.0
No. of shares m 7.45
% ch week % 4.3
% ch 1-mth % 3.4
% ch 12-mth % 9.8
52 week H/L Rs 7.2/3.3
(As on Jul 30, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

HULTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
HULTA PHARMA EQUITY SHARE DATA
High Rs910678 
Low Rs65444 
Sales per share (Unadj.) Rs00000.2 
Earnings per share (Unadj.) Rs-0.2-0.2-0.2-0.2-0.1 
Diluted earnings per shareRs-0.2-0.2-0.2-0.2-0.1 
Cash flow per share (Unadj.) Rs-0.2-0.2-0.2-0.2-0.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs0.60.40.20.1-0.1 
Adj. book value per shareRs0.60.40.20.1-0.1 
Shares outstanding (eoy) m7.457.457.457.457.45 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio xNMNMNMNM37.9 
Avg P/E ratio x-33.4-38.1-30.6-36.3-41.9 
P/CF ratio (eoy) x-33.4-38.1-30.7-36.5-42.0 
Price / Book Value ratio x13.017.420.662.6-115.1 
Dividend payout %00000 
Avg Mkt Cap Rs m5753374143 
No. of employees `000NANANANANA 
Total wages/salary Rs m00001 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
HULTA PHARMA INCOME DATA
Net Sales Rs m00001 
Other income Rs m00000 
Total revenues Rs m00001 
Gross profit Rs m-2-2-1-1-1 
Depreciation Rs m00000 
Interest Rs m00000 
Profit before tax Rs m-2-1-1-1-1 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00000 
Profit after tax Rs m-2-1-1-1-1 
Gross profit margin %NMNMNMNM-90.6 
Effective tax rate %00000 
Net profit margin %NMNMNMNM-91.1 
HULTA PHARMA BALANCE SHEET DATA
Current assets Rs m43200 
Current liabilities Rs m00000 
Net working cap to sales %NMNMNMNM-5.4 
Current ratio x12.68.04.43.50.8 
Inventory Days DaysNMNMNMNM107 
Debtors Days DaysNMNMNMNM0 
Net fixed assets Rs m00000 
Share capital Rs m7575757575 
"Free" reserves Rs m-70-72-73-74-75 
Net worth Rs m43210 
Long term debt Rs m00001 
Total assets Rs m53211 
Interest coverage x-84.5-137.0-121.0NMNM 
Debt to equity ratio x0000-1.7 
Sales to assets ratio x00001.9 
Return on assets %-35.5-40.3-54.2-144.5-175.4 
Return on equity %-38.8-45.7-67.6-173.0273.2 
Return on capital %-38.4-45.4-67.2-172.9-383.3 
Exports to sales %NMNMNMNM0 
Imports to sales %NMNMNMNM0 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
HULTA PHARMA CASH FLOW
From Operations Rs m -2 -1 -1 -1 -1 
From Investments Rs m 2 2 1 2 0 
From Financial Activity Rs m 0 0 0 0 1 
Net Cashflow Rs m 0 0 0 0 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 56.3%
Indian inst/Mut Fund 1.1%
FIIs 0.0%
ADR/GDR 0.0%
Free float 43.7%
Shareholders 3,506
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Regency House, 2 A Second Floor, 250/7 Anna Salai Teynampet, Chennai - 600006
E-MAIL epsomproperties@gmail.com WEB www.epsom.in
TEL 044- 4302 1233 FAX
SECTOR CONSTRUCTION GROUP Epsom Properties - MNC
TR AGENT Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
YEAR OF INC: 1987 BSE CODE: 531155 FV (Rs): 10 DIV YIELD (%): -

More Construction Company Fact Sheets:   ORTIN LABS   MEDICAMEN BI  GRANULES INDIA  SAMRAT PHARMA  MARKSANS PHARMA.  

Compare HULTA PHARMA With:   ORTIN LABS   MEDICAMEN BI  GRANULES INDIA  SAMRAT PHARMA  MARKSANS PHARMA.  




Today's Market

Sensex Ends 66 Points Lower; Bajaj Finance and Bajaj Finserv Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

OPEC & Our Next Crude Oil Trade (Fast Profits Daily)

Jul 20, 2021

This is why we are on the correct side of the crude oil trade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK HULTA PHARMA

  • Track your investment in HULTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON HULTA PHARMA

HULTA PHARMA 8-QTR ANALYSIS

COMPARE HULTA PHARMA WITH

MARKET STATS